Works matching IS 20445385 AND DT 2020 AND VI 10 AND IP 6

Results: 10
    1

    Repurposing anthelmintic agents to eradicate resistant leukemia.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0339-9
    By:
    • Mezzatesta, Caterina;
    • Abduli, Liridon;
    • Guinot, Anna;
    • Eckert, Cornelia;
    • Schewe, Denis;
    • Zaliova, Marketa;
    • Vinti, Luciana;
    • Marovca, Blerim;
    • Tsai, Yi-Chien;
    • Jenni, Silvia;
    • Aguade-Gorgorio, Julia;
    • von Stackelberg, Arend;
    • Schrappe, Martin;
    • Locatelli, Franco;
    • Stanulla, Martin;
    • Cario, Gunnar;
    • Bourquin, Jean-Pierre;
    • Bornhauser, Beat C.
    Publication type:
    Article
    2
    3
    4

    Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0336-z
    By:
    • Schinke, Carolina;
    • Boyle, Eileen M.;
    • Ashby, Cody;
    • Wang, Yan;
    • Lyzogubov, Valeriy;
    • Wardell, Christopher;
    • Qu, Pingping;
    • Hoering, Antje;
    • Deshpande, Shayu;
    • Ryan, Katie;
    • Thanendrarajan, Sharmilan;
    • Mohan, Meera;
    • Yarlagadda, Naveen;
    • Khan, Maliha;
    • Choudhury, Samrat Roy;
    • Zangari, Maurizio;
    • van Rhee, Frits;
    • Davies, Faith;
    • Barlogie, Bart;
    • Morgan, Gareth
    Publication type:
    Article
    5
    6

    A population-based study of chronic neutrophilic leukemia in the United States.

    Published in:
    2020
    By:
    • Ruan, Gordon J.;
    • Smith, Caleb J.;
    • Day, Courtney;
    • Harmsen, William S.;
    • Zblewski, Darci L.;
    • Alkhateeb, Hassan;
    • Begna, Kebede;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William;
    • Szuber, Natasha;
    • Gangat, Naseema;
    • Patnaik, Mrinal S.;
    • Pardanani, Animesh;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Go, Ronald S.;
    • Shah, Mithun V.
    Publication type:
    Letter
    7

    Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0333-2
    By:
    • Caocci, Giovanni;
    • Mulas, Olga;
    • Capodanno, Isabella;
    • Abruzzese, Elisabetta;
    • Iurlo, Alessandra;
    • Luciano, Luigiana;
    • Albano, Francesco;
    • Annunziata, Mario;
    • Tiribelli, Mario;
    • Bonifacio, Massimiliano;
    • Galimberti, Sara;
    • Castagnetti, Fausto;
    • Sgherza, Nicola;
    • Stagno, Fabio;
    • Gozzini, Antonella;
    • Orlandi, Ester Maria;
    • Luzi, Debora;
    • Binotto, Gianni;
    • Pregno, Patrizia;
    • Fozza, Claudio
    Publication type:
    Article
    8
    9
    10

    A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0330-5
    By:
    • Collignon, A.;
    • Hospital, M. A.;
    • Montersino, C.;
    • Courtier, F.;
    • Charbonnier, A.;
    • Saillard, C.;
    • D'Incan, E.;
    • Mohty, B.;
    • Guille, A.;
    • Adelaïde, J.;
    • Carbuccia, N.;
    • Garnier, S.;
    • Mozziconacci, M. J.;
    • Zemmour, C.;
    • Pakradouni, J.;
    • Restouin, A.;
    • Castellano, R.;
    • Chaffanet, M.;
    • Birnbaum, D.;
    • Collette, Y.
    Publication type:
    Article